Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors

Peptide receptor radionuclide therapy (PRRT) is an established treatment in advanced neuroendocrine tumors (NETs), which overexpressed somatostatin receptors. However, after progression there are a limited number of available treatments. We want to share a case report about a patient with a NET re-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vida Navas, Elena María, Martínez Lorca, Alberto, Sancho Gutiérrez, Aintzane, Sanz Gómez, Lucia, Navarro Martínez, Teresa, Grande Pulido, Enrique, Carrato Mena, Alfredo, Gajate Borau, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082310/
https://www.ncbi.nlm.nih.gov/pubmed/33935979
http://dx.doi.org/10.3389/fendo.2021.676973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082310/
https://www.ncbi.nlm.nih.gov/pubmed/33935979
http://dx.doi.org/10.3389/fendo.2021.676973

Ejemplares similares